Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
Arbutus Biopharma Corp reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Arbutus Biopharma Corp reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, four executives at Arbutus Biopharma Corp received on average a compensation package of $2M, a 12% increase compared to previous year.
Average pay of disclosed executives at Arbutus Biopharma Corp
Mark Murray, Chief Executive Officer, received $3.8M in total, which increased by 50% compared to 2018.
William H. Collier, Chief Executive Officer, received a compensation package of $2.3M. 77% of the compensation package, or $1.8M, was in option awards.
Michael Sofia, Chief Scientific Officer, earned $1.1M in 2019.
David C. Hastings, Chief Financial Officer, received $1M in 2019, which decreases by 30% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 24, 2020.